J&J said it would buy Intra-Cellular Therapies in a deal worth $14.6 billion, another sign of large drugmakers’ reentry into ...

Duke neuroscientist Kafui Dzirasa wants nothing less than to reengineer the brain’s electrical patterns to treat anxiety, ...

LONDON — Seeking to build up its cancer business, GSK said Monday it is buying the privately held U.S. biotech IDRx for $1 ...

Cigna and Centene were among a dozen companies that appeared on the initial JPM agenda that have bowed out of the conference.

Asian American populations, particularly when broken down into ethnic groups, have allergy health outcomes that are distinct ...

This amounts to one of the most significant federal government investments in the behavioral health sector in history. For ...

Many new names sounded as if they’d been cooked up by a medieval monk. HIV-1 would henceforth be known as Lentivirus ...

The Food and Drug Administration on Friday cleared Eli Lilly’s obesity drug Zepbound as the first treatment for a common sleep disorder in the U.S. Zepbound, whose scientific name is tirzepatide ...

Documents show Robert F. Kennedy Jr. invested in biotech companies and consulted on health care — interests he might have to ...

Enrollment of Black and Hispanic students in medical schools dropped precipitously last year after the Supreme Court banned ...

The changes reflect “a cultural shift” around obesity medications, said Diana Zuckerman, president of the nonprofit National ...

Basic public health protections help augment our national security protections,” particularly when it comes to emerging ...